 |
|
Gene with probable role in human susceptibility to pulmonary tuberculosis identified
October 09, 2008Males are more likely to contract the disease
A new gene that may confer susceptibility to pulmonary tuberculosis has been identified by Genome Institute of Singapore (GIS) researchers and their collaborators in The Netherlands, Indonesia, United Kingdom, and the Russian Federation.
In the current j PLoS Genetics, the scientists report that the gene, named Toll-like receptor 8 (TLR8), which had been previously shown to recognize some factors from viruses such as the human immunodeficiency virus (HIV), also has a probable role in human susceptibility to Mycobacterium tuberculosis infections.
The study also found that males are more susceptible than females.
"We are really excited about this discovery as it is the first time TLR8 has been implicated in bacteria infections," said Dr. Sonia Davila, GIS Research Scientist and first author of the article.
"Our analysis of the results from cohort studies in Indonesia and Russia suggested that susceptibility was attributed to genetic variants of TLR8, which is located at the X chromosome.
"Males carrying only one copy of the gene could have a higher chance of suffering from the disease," Dr. Davia added. "These findings open up a whole new area of research and we hope that it will increase our understanding of the disease process of pulmonary tuberculosis."
GIS Senior Group Leader and Associate Director of Infectious Diseases, Dr. Martin Hibberd noted, "This project is a great example of international teams coming together to solve a difficult problem, with groups from Indonesia, Singapore, UK, Russia and the Netherlands playing important roles. We hope that this work can initiate further research that will make a difference to people suffering from TB".
"The team from the Genome Institute led by Drs. Davila, Seielstad and Hibberd has made an important new discovery of an alternative cellular receptor for one of the world's most important infectious agents, M. tuberculosis, the causative agent of TB," said Dr. Paul MacAry, Assistant Professor at National University of Singapore Graduate School for Integrative Sciences and Engineering.
"The identification of a role for TLR8 in TB infection has the potential to open up new areas of exploration in TB host/pathogen interactions and provide researchers and clinician scientists with novel targets for therapeutic intervention," Dr. MacAry added. "This is extremely important given the emergence of multi-drug resistant strains of M.tuberculosis that are refractive to current treatment regimes."
Pulmonary tuberculosis is a contagious lung disease caused by a bacterium known as Mycobacterium tuberculosis (M. tuberculosis). Although a third of the world population is infected with M. tuberculosis, only 5 to 10% of them will ever develop tuberculosis, giving rise to a proposition that there may be a difference in genetic variants within the genes involved in host immune response.
Agency for Science, Technology and Research (A*STAR), Singapore
The study also found that males are more susceptible than females.
"We are really excited about this discovery as it is the first time TLR8 has been implicated in bacteria infections," said Dr. Sonia Davila, GIS Research Scientist and first author of the article.
"Our analysis of the results from cohort studies in Indonesia and Russia suggested that susceptibility was attributed to genetic variants of TLR8, which is located at the X chromosome.
"Males carrying only one copy of the gene could have a higher chance of suffering from the disease," Dr. Davia added. "These findings open up a whole new area of research and we hope that it will increase our understanding of the disease process of pulmonary tuberculosis."
GIS Senior Group Leader and Associate Director of Infectious Diseases, Dr. Martin Hibberd noted, "This project is a great example of international teams coming together to solve a difficult problem, with groups from Indonesia, Singapore, UK, Russia and the Netherlands playing important roles. We hope that this work can initiate further research that will make a difference to people suffering from TB".
"The team from the Genome Institute led by Drs. Davila, Seielstad and Hibberd has made an important new discovery of an alternative cellular receptor for one of the world's most important infectious agents, M. tuberculosis, the causative agent of TB," said Dr. Paul MacAry, Assistant Professor at National University of Singapore Graduate School for Integrative Sciences and Engineering.
"The identification of a role for TLR8 in TB infection has the potential to open up new areas of exploration in TB host/pathogen interactions and provide researchers and clinician scientists with novel targets for therapeutic intervention," Dr. MacAry added. "This is extremely important given the emergence of multi-drug resistant strains of M.tuberculosis that are refractive to current treatment regimes."
Pulmonary tuberculosis is a contagious lung disease caused by a bacterium known as Mycobacterium tuberculosis (M. tuberculosis). Although a third of the world population is infected with M. tuberculosis, only 5 to 10% of them will ever develop tuberculosis, giving rise to a proposition that there may be a difference in genetic variants within the genes involved in host immune response.
Agency for Science, Technology and Research (A*STAR), Singapore
Pulmonary Tuberculosis Current Events and Pulmonary Tuberculosis News RSSHealth Care Barriers for Undocumented Immigrants: Raising Tuberculosis Risk?
A new study raises the question, do barriers to health care for undocumented immigrants increase the public health risk of tuberculosis? The study, published in the November 15, 2008 issue of Clinical Infectious Diseases and now available online, suggests that undocumented immigrants with tuberculosis have symptoms longer before seeking care than documented immigrants or U.S.-born patients, resulting in more severe symptoms and more opportunities for transmission.
Scientists identify gene that may make humans more vulnerable to pulmonary tuberculosis
Researchers from the Genome Institute of Singapore (GIS) and its collaborators have now identified for the first time a new gene that may confer susceptibility to pulmonary tuberculosis.
Obesity associated with a lower risk of tuberculosis in older Chinese population
Obese or overweight Chinese individuals age 65 and older have a lower risk of developing tuberculosis than those at a normal weight.
New international standards for tuberculosis care published
Led by the American Thoracic Society (ATS) and the World Health Organization (WHO), a consortium of international health agencies today published on the World Wide Web the first International Standards for Tuberculosis Care (ISTC).
New vaccine protects more effectively against tuberculosis
Globally, tuberculosis remains the number one killer in adults. Moreover, multi-drug-resistant tuberculosis strains are on the rise which cannot be treated by first-line drugs.
A possible ancient origin for tuberculoses in Casablanca
Each year tuberculosis kills about three million people in the world. In particular it is responsible for the death of more than one-third of HIV- infected people, who prove particularly susceptible owing to a decline in immune defences. The agent responsible is a bacterium of the species Mycobacterium tuberculosis, also termed Koch's bacillus, after the scientist who discovered it in 1882.
INCREASED RISK OF TUBERCULOSIS RECURRENCE IN PEOPLE WITH HIV-1 INFECTION (pp 1470, 1488)
People with HIV-1 infection are at an increased risk of recurrent tuberculosis, and could benefit from preventative treatment after the first episode of the disease, concludes research published in this week's issue of THE LANCET. Patients with HIV-1 infection respond well to treatment for active tuberculosis, but whether such patients are at increased risk of disease recurrence after successful treatment is uncertain. As a result, most experts do not recommend more intensive tuberculosis therapy for HIV-1-infected individuals than for uninfected people, and do not recommend prophylaxis after curative treatment. Jean William Pape and colleagues from New York Hospital-Cornell Medical Centre,
More Pulmonary Tuberculosis Current Events and Pulmonary Tuberculosis News Articles
 | Tuberculosis (TUBERCULOSIS ( ROM)) New York Univ., NY. Summarizes the current advances in tuberculosis and discusses the pathology and pathogenesis of the disease. Also covers complications and treatment options. Chapters include history and epidemiology, genomics and microbiology, host response, therapy, and prevention and control. Previous edition: c1996. DNLM:... |
 | Pulmonary Tuberculosis: Its Etiology, Symptomatology and Therapeutics by David Jessup Doherty, Hugo Ziemssen |
| Kaposi sarcoma secondary to pulmonary tuberculosis: a rare case.(Case Report): An article from: Southern Medical Journal by Zuhal Mujgan Guler, Asiye Kanbay, Bulent Ciftci, Mehmet Kanbay, Aydin Yilmaz, Yetkin Agackiran, Yurdanur Erdogan This digital document is an article from Southern Medical Journal, published by Thomson Gale on September 1, 2005. The length of the article is 1179 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle:... | |
 | Quinolones in Pulmonary Tuberculosis Management by Lascolea This state-of-the-art reference provides detailed information on the use of quinolone antibiotics and other antibiotic regimens in the management of pulmonary tuberculosis;offering in-depth coverage of the history, epidemiology, clinical presentation, diagnosis, immunopathology, and immunotherapy of tuberculosis for the nonspecialist. Covering all major topics related to tuberculosis infection,... |
| Pulmonary Tuberculosis: A Journey Down the Centuries by Robert Young Keers | |
| Pulmonary Tuberculosis: Its Modern Prophylaxis and the Treatment in Special Instituions and at Home. Alvarenga Prize Essay of the College of Physicians of Philadelphia for the Year 1898 Revised and Enlarged. by S.A. KNOPF | |
| PATHOLOGY OF THE LUNG (EXCLUDING PULMONARY TUBERCULOSIS) by H SPENCER | |
| PULMONARY TUBERCULOSIS: PATHOLOGY, DIAGNOSIS, MANAGEMENT AND PREVENTION (OXFORD MEDICAL PUBLICATIONS SERIES) by GEORGE GREGORY KAYNE | |
| Artificial Pneumothorax : Its Practical Application in the Treatment of Pulmonary Tuberculosis by Edward N.; Hayes, John N.; Blanchet, Sidney F. (editors) Packard | |
| Rifampicin in Extra Pulmonary Tuberculosis: Royal Society of Medicine Symposium Proceedings (International congress and symposium series / Royal Society of Medicine) |
| © 2009 BrightSurf.com |